5 Stomach Cancer Clinical Trials in Boston, MA (2026)

Q: How do I join a clinical trial in Boston?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you.

Recruiting Stomach Cancer Studies in Boston

NCT06731478Recruiting

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

This clinical trial is designed to assess the efficacy and safety of the triplet combination of trastuzumab deruxtecan (ENHERTU, T-DXd, DS-8201a) plus a fluoropyrimidine plus pembrolizumab versus stan...

Boston, MAPHASE3726 participantsDaiichi Sankyo

View Study Details

NCT05482893Recruiting

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

This is a first-in-human, Phase 1/2, open-label, dose escalation and dose expansion and combination study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and prelimi...

Boston, MAPHASE1350 participantsPhanes Therapeutics

View Study Details

NCT04674267Recruiting

Resilience and Equity in Aging, Cancer, and Health (REACH)

The purpose of this multi-phase research study is to understand how consultation of cancer care with a geriatrician can best improve outcomes for older adults with gastrointestinal malignancies....

Boston, MANA147 participantsDana-Farber Cancer Institute

View Study Details

NCT04368702Recruiting

CONFIRM: Magnetic Resonance Guided Radiation Therapy

This research is being done to determine the safety and feasibility of using a type of radiation guided by magnetic resonance imaging (MRI) and chemotherapy to treat patients with gastric and breast c...

Boston, MANA70 participantsBrigham and Women's Hospital

View Study Details

NCT07070466Recruiting

Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

This is a single arm, open-label, phase II trial investigating the combination of ivonescimab with standard FOLFOX chemotherapy in 1L therapy for HER2- GEA....

Boston, MAPHASE240 participantsMassachusetts General Hospital

View Study Details

About Stomach Cancer Clinical Trials in Boston

Stomach (gastric) cancer develops in the lining of the stomach and is more common in certain regions of the world. Risk factors include H. pylori infection, smoking, and diet. Treatment includes surgery, chemotherapy, radiation, and immunotherapy.

There are currently 5 stomach cancer clinical trials recruiting participants in Boston, MA. These studies are seeking a combined 1,333 participants. Research is being sponsored by Daiichi Sankyo, Phanes Therapeutics, Dana-Farber Cancer Institute and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Stomach Cancer Clinical Trials in Boston — FAQ

Are there stomach cancer clinical trials in Boston?

Yes, there are 5 stomach cancer clinical trials currently recruiting in Boston, MA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Boston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.

Are clinical trials in Boston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.

What stomach cancer treatments are being tested?

The 5 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for stomach cancer.

Data updated October 15, 2026 from ClinicalTrials.gov